English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
American Academy Of Neurology
Sam Jackson
| Apr 25, 2023
Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'
Sam Jackson
| Apr 25, 2023
New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'
Press release submission
| May 2, 2019
AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
Robert Hadley
| May 16, 2017
Immunosuppressive drug cladribine may slow progression of MS
Ruth de Jauregui
| May 7, 2017
Data from multiple sclerosis medication study shows promise
Robert Hadley
| May 3, 2017
Clinical trial results offer hope for multiple sclerosis sufferers
Amanda Rupp
| May 22, 2016
New ALS research announced at annual conference
Amanda Rupp
| Apr 21, 2016
ALS Association announces new research fellowships
Trending
Patient Daily
| Oct 9, 2025
Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+
Technology/Innovation
Patient Daily News Service
| Oct 9, 2025
Babylon Health collapse raises questions about AI claims across industries
Patient Daily
| Oct 9, 2025
AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+
Regulatory
Patient Daily
| Oct 14, 2025
Mackinac Center raises concerns over federal 340B drug pricing program’s market impact